Prevalence of end stage renal disease and associated conditions in hemodialysis Iraqi patients
Keywords:Disease, End stage, Hemodialysis, Renal
Background: Chronic Kidney Disease (CKD) is the third most common non-communicable disease throughout the world. Most of the patients with chronic kidney disease suffer from hypertension, diabetes and with glomerulonephritis. Many of these CKD patients ultimately terminate to End Stage Renal Disease (ESRD) when life is not sustainable unless hemodialysis is initiated. This study was to identify systemic and renal disease leading to ESRD requiring hemodialysis and associated co-morbidities.
Methods: Data was collected from three selected three hemodialysis centers in three hospitals during one-year study in Iraq. Patients were selected purposively who were available at the time of interview. Data was collected on working days at three shifts. these data collected from patients and their relatives in these centers after taking informed consent from patients the pre-tested questionnaire was filled up by taking general history, family history, socioeconomic condition, drug history and available records were reviewed for collecting previous biochemical parameters. All entered data were analyzed by using SPSS program.
Results: Among total 400 subjects, male was 260 (65%) and female 140 (35%). Majority of patients were middle aged. Glomerulonephritis were found to be the leading cause of End Stage Renal Disease (ESRD) (50.4%), followed by diabetes in 31.1%, Poly Cystic Kidney Disease (PKD) 5.3%, Renal Stone in 3.7% and rest other. Among the study population hypertension was the most common co morbidity disease (63%) followed by ischemic heart disease and Cerebrovascular accidents.
Conclusions: The leading cause of End Stage Renal Disease (ESRD) was the glomerulonephritis and diabetic nephropathy was the second common cause. Hypertension was the most common associated co morbid disease.
Francesco PS. Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy. Kidney International. 2000;57(74):S-39-S-45.
Renal Data System. USRDS; Annual Data Report. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1996.
Stevens LA, Viswanathan G, Weiner DE. CKD and ESRD in the Elderly: Current Prevalence, Future Projections, and Clinical Significance. Adv Chronic Kidney Dis. 2010 July;17(4):293-301.
MV. More frequent hemodialysis: back to the future? In: Advances in Chronic Kidney Disease. 2007;14(3):e1-9.
De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) the rapiesan international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant. 1999;14(6):31-41.
Berthoux F, Jones E, Gellert R, Mendel S, Saker L, Briggs D. Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries. Nephrology Dialysis Transplantation. 1999 Oct 1;14(10):2332-42.
Ahmad S, Misra M, Hoenich N, Daugirdas J. Hemodialysis Apparatus. In: Handbook of Dialysis. 4th Ed. New York, NY; 2008:59-78.
Jha V, Chugh KS. Dialysis in developing countries: Priorities and obstacles. Nephrology 1996; 2: 65-72.
Li L. Nephrology forum. End-stage renal disease in China. Kidney Int. 1996;49:287-301.
Abbasi MA, Chertow GM, Hall YN. End-stage renal disease. BMJ clinical evidence. 2010;2010.
Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. New England Journal of Medicine. 2000;342(20):1478-83.
Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Annals of internal medicine. 2006;144(1):21-8.